RxDoctor Payments Data

Gregory Roehrig, MD

Adult Reconstructive Orthopaedic Surgery · Manasquan, NJNPI 1477562890

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Corin USA at 49.8% of the total. Reporting peaked in 2019 at $38,609 and has fallen 92.6% since, to $2,847 in 2025.

$75,134in general payments, 2019–2025

Across 119 payments — averaging $631.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corin USA$37K
  • Smith+Nephew$14K
  • Zimmer Biomet$9K
  • Omnilife Science, Inc$6K
  • Bodycad USA Corp$5K
  • Nextstep Arthropedix, LLC$1K
  • plus $3K from 16 others

What the payments were for

  • Consulting fees$42,40056%
  • Speaking & faculty fees$4,1255%
  • Travel & lodging$23,15931%
  • Food & beverage$3,6315%
  • Education$1,7052%
  • Gifts$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$75,134 in reported general payments places this provider in the 75th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.

See all adult reconstructive orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$352,606
Medicare patients
629
Services billed
1,968

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium ErDiclofenac Sodium37$1,256
Celecoxib43$1,087
Fentanyl18$954
Oxycodone Hcl55$692
Cephalexin106$557
Diclofenac Sodium19$201
Tramadol Hcl42$181
Methylprednisolone21$109
Meloxicam44$96
Mupirocin14$82
Clindamycin Hcl13$40

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Manasquan

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →